Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
APPLICATION OF SCD100 PROTEIN IN PREPARING DRUG FOR TREATING CHRONIC HBV INFECTION
Document Type and Number:
WIPO Patent Application WO/2019/001173
Kind Code:
A1
Abstract:
The present invention provides an application of a sCD100 protein in preparing a drug for treating chronic HBV infection, and further provides a drug for treating chronic HBV infection, with an active component being the sCD100 protein.

Inventors:
LIU JIA (CN)
WANG LU (CN)
YANG SHANGQING (CN)
YANG DONGLIANG (CN)
Application Number:
PCT/CN2018/087754
Publication Date:
January 03, 2019
Filing Date:
May 22, 2018
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
UNION HOSPITAL TONGJI MEDICAL COLLEGE HUAZHONG UNIV OF SCIENCE AND TECHNOLOGY (CN)
International Classes:
A61K38/17; A61P1/16; A61P31/20
Foreign References:
CN107375902A2017-11-24
Other References:
YANG, SHANGQING ET AL.: "Refulatin of antiviral CN 8 T cell response by Sema4D/ CD 100 and its soluble form in HBV infection", DISCUSSIONS AND LECTURES OF THE 11 TH CHINA NATIONAL IMMUNOLOGY ACADEMIC CONFERENCE SESSION, 4 November 2016 (2016-11-04)
HE, YU ET AL.: "Alteration of CD 100 Expression on Natural Killer Cells in Chronic Patients with Hepatitis C Virus Before and After Initiation of Antiviral Treatment", CHINESE JOURNAL OF CELLULAR AND MOLECULAR IMMUNOLOGY, 31 December 2014 (2014-12-31)
Attorney, Agent or Firm:
WUHAN ZHI QUAN PATENT AGENCY (CN)
Download PDF: